← FDA DRUG APPROVALS

FDA ANDA · ANDA216990

VENXXIVA

tiopronin

Sponsor: TORRENT

APPLICATION
ANDA216990
TYPE
ANDA
ORIGINAL APPROVAL
2024-01-30
LATEST ACTION
2024-07-26
ROUTE
ORAL
DOSAGE FORM
TABLET, DELAYED RELEASE
MARKETING STATUS
Prescription

Products

VENXXIVAPrescription
TIOPRONIN 100MG · TABLET, DELAYED RELEASE · ORAL
VENXXIVAPrescription
TIOPRONIN 300MG · TABLET, DELAYED RELEASE · ORAL

Approval history

2024-07-26Labeling · Supplement 1 · standardAP
2024-01-30UNKNOWN · Original · standardLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →